Journal of Adolescent Health
Volume 45, Issue 3 , Pages 262-267 , September 2009

Attitudes Toward the Vaginal Ring and Transdermal Patch Among Adolescents and Young Women

  • Tina R. Raine, M.D., M.P.H.

      Affiliations

    • Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California–San Francisco, San Francisco, California
    • Corresponding Author InformationAddress correspondence to: Tina R. Raine, M.D., M.P.H., Department of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco General Hospital–6D, 1001 Potrero, San Francisco, CA 94110.
    • ,
  • Laura B. Epstein, B.A.

      Affiliations

    • University of California Berkeley/University of California–San Francisco Joint Medical Program, San Francisco, California
    • ,
  • Cynthia C. Harper, Ph.D.

      Affiliations

    • Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California–San Francisco, San Francisco, California
    • ,
  • Beth A. Brown, M.A., M.P.A.

      Affiliations

    • Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California–San Francisco, San Francisco, California
    • ,
  • Cherrie B. Boyer, Ph.D.

      Affiliations

    • Division of Adolescent Medicine, Department of Pediatrics, University of California–San Francisco, San Francisco, California

Received 18 October 2008 ,Accepted 3 February 2009.

References 

  1. Henshaw S. Unintended Pregnancy in the United States. Fam Plann Perspect. 1998;30:24–29
  2. Finer LB, Henshaw S. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38:90–96
  3. Santelli JS, Lindberg LD, Finer LB, Singh S. Explaining recent declines in adolescent pregnancy in the United States: The contribution of abstinence and improved contraceptive use. Am J Public Health. 2007;97:150–156
  4. Dieben TOM, Roumen FJME, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol. 2002;100:585–593
  5. Weisberg E, Fraser IS, Misell DR, et al. The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring. Contraception. 1995;51:39–44
  6. Szarewski A. High acceptability and satisfaction with NuvaRing® use. Eur J Contracept Reprod Health Care. 2002;7(Suppl 2):31–39
  7. Audet M, Moreau M, Koltun WD, et al. Ortho Evra/Evra 004 Study Group Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive, a randomized controlled trial. J Am Med Assoc. 2001;285:2347–2354
  8. Zeiman M, Guillebaud J, Weisberg E, et al. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: The analysis of pooled data. Fertil Steril. 2002;77:S13–S18
  9. Oddsson K, Leifels-Fischer B, Wiel-Masson D, et al. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: A randomized trial. Hum Reprod. 2005;20:557–562
  10. Bixby Center for Reproductive Health Research and Policy in the Department of Obstetrics, Gynecology, and Reproductive Sciences, FamilyPACT Program Report FY 06/07, FamilyPACT Program. San Francisco, CA: University of California, San Francisco; 2008;
  11. Timmer CJ, Mulders TM. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet. 2000;39:233–242
  12. van den Heuvel MW, van Bragt AJM, Alnabawy AKM, Kaptein MCJ. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: The vaginal ring, the transdermal patch and an oral contraceptive. Contraception. 2005;72:168–174
  13. Cole JA, Norman H, Doherty M, Walker AM. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol. 2007;109:339–346
  14. Epstein LB, Sokal-Gutierrez K, Ivey S, Raine T, Auerswald C. Adolescent experiences with the vaginal ring. J Adolesc Health. 2008;43:64–70
  15. Stewart FH, Brown BA, Raine TR, et al. Adolescent and young women's experience with the vaginal ring and oral contracpetive pills. J Pediatr Adolesc Gynecol. 2007;6:345–351
  16. Morse JM. Critical Issues in Qualitative Research. Newbury Park, California: Sage Publications; 1994;
  17. Morgan D, Krueger R. The Focus Group Kit: The Focus Group Guidebook. Thousand Oaks, California: Sage Publications; 1998;
  18. Miles MB, Huberman AM. Qualitative Data Analysis: An Expanded Sourcebook, 2nd ed. Thousand Oaks, California: Sage Publications; 1993;
  19. Ajzen I, Fishbein M. Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, New Jersey: Prentice-Hall; 1980;
  20. Halpern CJT, Udry JR, Suchindran C, Campell B. Adolescent males' willingness to report masturbation. J Sex Res. 2000;37:327–332
  21. Rodgers JE, Billy JOG, Udry JR. The rescission of behaviors: Inconsistent responses in adolescent sexuality data. Soc Sci Res. 1982;11:280–296
  22. Frost L. Young Women and the Body: A Feminist Sociology. Houndmills Basingstoke Hampshire. United Kingdom: Palgrave; 2001;
  23. Oinas E. Medicalisation by whom? Accounts of menstruation conveyed by young women and medical experts in medical advisory columns. Sociol Health Illn. 1998;20:52–70
  24. El-bassel N, Krishnan SP, Schilling RF, et al. Acceptability of the female condom among STD clinic patients. AIDS Educ Prev. 1998;10:465–480
  25. Eldrige GD, St. Lawrence JS, Little CE, et al. Barriers to condom use and barrier method preferences among low-income African-American women. Women Health. 1995;23:73–89
  26. Choi KH, Roberts KJ, Gomez C, Grinstead O. Facilitators and barriers to use of the female condom: Qualitative interviews with women of diverse ethnicity. Women Health. 1999;30:53–70
  27. Kulczycki A, Kim DJ, Duerr A, et al. The acceptability of the female and male condom: A randomized crossover trial. Perspect Sex Reprod Health. 2004;36:114–119
  28. Harvey SM, Bird ST, Maher JE, Beckman LJ. Who continues using the diaphragm and who doesn't: Implications for the acceptability of the female-controlled HIV prevention methods. Women's Health Issues. 2003;13:185–193
  29. Maher JE, Harvey SM, Bird ST, et al. Acceptability of the vaginal diaphragm among current users. Perspect Sex Reprod Health. 2004;36:64–71
  30. FDA News. FDA Approves Update to Label on Birth Control Patch [Online]. Available at: http://www.fda.gov/bbs/topics/NEWS/2008/NEW01781.html. Accessed January 13, 2009.
  31. Jick S, Kaye JA, Jick H. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 μg of EE. Contraception. 2007;76:4–7

PII: S1054-139X(09)00105-0

doi: 10.1016/j.jadohealth.2009.02.007

Journal of Adolescent Health
Volume 45, Issue 3 , Pages 262-267 , September 2009

Article Tools